“The BioPark is a bridge,” said Jay A. Perman, MD,

“The BioPark is a bridge,” said Jay A. Perman, MD, president of the University of Maryland, Baltimore (UMB).

“It’s a bridge to take discoveries to market, through UMB’s vast discovery pipeline,” Perman explained.

UM BioPark Tenant Acquired for $1.2 Billion

https://www.umaryland.edu/news/archived-news/...ired-f.php

Paragon Bioservices, now a part of Catalent Biologics, is an industry-leading contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon’s aim is to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic protein, and other complex biologics.

https://paragonbioservices.com

$$$$UNVC$$$$